ISPOR - PMH13 ESTIMATING THE BENEFIT OF LONG-ACTING INJECTABLES FOR SCHIZOPHRENIA TREATMENT IN RWANDA USING A ONE-YEAR COST-CONSEQUENCE MODEL

Full Text

PMH13 ESTIMATING THE BENEFIT OF LONG-ACTING INJECTABLES FOR SCHIZOPHRENIA TREATMENT IN RWANDA USING A ONE-YEAR COST-CONSEQUENCE MODEL

Abstract

Authors

T. Thomas A. Keenan A. Ngirababyeyi K. Mwaniki J.D. Iyamuremye V. Smith-Swintosky E. Abraham Y. Kayiteshonga B. Rutakayire S. Kanyandekwe

Back to Volume 22, Supplemental S2

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now